← FDA Drug Approvals (Drugs@FDA)

OLINVYK

NDA · New Drug Application · Sponsor: TREVENA · Approved 2020-08-07

Drug application

FDA Application #

NDA210730

Application type

New Drug Application

Brand name

OLINVYK

Generic name

OLICERIDINE

Active ingredients

OLICERIDINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

TREVENA

Manufacturer

Trevena, Inc.

First approval

2020-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown